A single dose of nicotinamide riboside (NR) may significantly increases levels of NAD+, which is key to cellular energy metabolism and mitochondrial function, says a new study with healthy human volunteers using ChromaDex’s Niagen NR.
The science to support the potential benefits of nicotinamide riboside for age-related conditions continues to grow, with a new study from Europe indicating the compound may boost the number and size of mitochondria.
The success and demand for Chromadex’s Niagen-branded nicotinamide riboside ingredient are driving ingredient sales for the Californian company, with more research to be published expected to further boost the ingredient.
A new agreement between Chromadex and the Brazilian Biosciences National Laboratory (LNBio) to evaluate ChromaDex's natural product libraries could lead to ‘rapid commercialization of novel natural products for food, beverage, cosmetic or pharmaceutical applications’.
The potential of nicotinamide riboside, the next generation vitamin B3, goes beyond dietary supplements, into functional food and beverages, medical foods, infant nutrition and more, says the CEO of Chromadex.
Buoyed by recent investment from DSM, the CEO of Chromadex says the company is not scared to spend big to develop ingredients that stand up to increased scientific scrutiny and resonate with the market.
New ‘suspect alkaloids’ are finding their way into the controversial pre-workout supplement sector, and potentially dangerous products will continue to flourish in the marketplace while there is wider support from the industry, according to the CEO of Chromadex.
Natural products firm ChromaDex Corp. has entered into a material transfer agreement with Universite Libre de Bruxelles (ULB), under which ChromaDex will provide ULB with its recently launched Niagen nicotinamide riboside (NR).
Over 70% of Americans may be interested in reduced caffeine energy beverages that can offer the boost of caffeine but without the crash, according to a new survey conducted by Ipsos Research and commissioned by Chromadex.
Heads or tails, the yin and the yang – there are two sides to everything, and the same can be said for the ‘antioxidant’ debate. In this guest article, Steve Baugh, Technical Services Director of ChromaDex Analytics Inc, gives us his views on antioxidants and pro-oxidants, and the potential rise...